Filter
1208
Filtered Results: 1208
Text search:
rapid
laboratory
confirmation
Featured
Recommendations
177
New Publications
359
Language
Document type
No document type
709
Guidelines
233
Studies & Reports
110
Strategic & Response Plan
60
Manuals
58
Fact sheets
14
Situation Updates
13
Training Material
9
Resource Platforms
1
Infographics
1
Countries / Regions
India
73
Global
37
Kenya
31
South Africa
30
Western and Central Europe
30
Ethiopia
28
Liberia
27
Nigeria
26
Sierra Leone
25
Africa
23
Congo, Democratic Republic of
22
Uganda
20
Latin America and the Carribbean
19
Malawi
18
Tanzania
17
Rwanda
17
Eastern Europe
17
Zambia
16
Nepal
14
Ghana
13
East and Southern Africa
13
West and Central Africa
13
Zimbabwe
11
Philippines
11
Guinea
9
Senegal
9
Syria
9
Bangladesh
9
Colombia
9
Haiti
8
Madagascar
8
Argentina
7
Ukraine
7
Myanmar / Burma
7
Middle East and North Africa
7
Namibia
6
Ecuador
6
South–East Asia Region
6
Asia
6
Cameroon
5
Somalia
5
Pakistan
5
Botswana
5
Western Pacific Region
5
Burkina Faso
4
Mali
4
South Sudan
4
Mozambique
4
Eswatini/ Swaziland
4
Brazil
4
Lesotho
4
Eastern Europe and Central Asia
4
Niger
3
Cambodia
3
Benin
3
Yemen
3
Venezuela
3
Albania
3
Côte d’Ivoire / Ivory Coast
2
Togo
2
Afghanistan
2
Germany
2
Lebanon
2
Turkey
2
Gambia
2
Peru
2
North Macedonia
2
El Salvador
2
Chile
2
Paraguay
2
Russia
2
Georgia
2
France
2
Spain
2
Guinea-Bissau
1
Morocco
1
USA
1
Saudi Arabia
1
Iraq
1
Jordan
1
Chad
1
China
1
Indonesia
1
Sudan
1
Central African Republic
1
Dominican Republic
1
Cuba
1
Burundi
1
Honduras
1
Bolivia
1
Greece
1
Angola
1
Guatemala
1
Mexico
1
Nicaragua
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Estonia
1
Iran
1
Vietnam
1
North America
1
Uruguay
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
468
Clinical Guidelines
177
Public Health
50
Pharmacy & Technologies
42
Key Resources
33
Women & Child Health
24
Capacity Building
15
Toolboxes
TB
163
Rapid Response
133
COVID-19
130
HIV
79
NTDs
72
Ebola
53
Cholera
35
Zika
28
AMR
21
Polio
19
Pharmacy
13
Conflict
11
Natural Hazards
10
Mental Health
10
Caregiver
10
Planetary Health
8
Refugee
7
Specific Hazards
4
NCDs
3
Disability
2
Global Health Education
2
Health Financing Toolbox
1
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
